Form 4: Tango Therapeutics President Sells Shares

Sentiment:

Insider Transaction (Form 4)


Adam Crystal, President, R&D of Tango Therapeutics, Inc., sold 27,000 shares of common stock on August 3, 2026.

Summary

  • Option exercise/conversion: acquired 27,000 Common Stock at $5.20 ($140,400) on August 3, 2026; holds 142,743 after (Direct).
  • Open-market sale: disposed of 5,267 Common Stock at $26.79 ($141,100) on August 3, 2026; holds 137,476 after (Direct).
  • Open-market sale: disposed of 21,733 Common Stock at $27.35 ($594,417) on August 3, 2026; holds 115,743 after (Direct).
  • Option exercise/conversion: disposed of 27,000 Stock Option (Right to Buy) on August 3, 2026; holds 287,040 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $735,517 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Adam Crystal — Officer (President, R&D)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-03Option exercise/conversionCommon Stock27,000$5$140.4K142,743
2026-08-03Open-market saleCommon Stock5,267$27$141.1K137,476
2026-08-03Open-market saleCommon Stock21,733$27$594.4K115,743
2026-08-03Option exercise/conversionStock Option (Right to Buy)27,000——287,040

Key Dates

DateDescription
2026-08-03Option exercise/conversion (27,000 shares)
2026-08-03Open-market sale (5,267 shares)
2026-08-03Open-market sale (21,733 shares)
2026-08-03Option exercise/conversion (27,000 shares)

Keywords

insider transaction, Form 4, TNGX, Tango Therapeutics, Inc., bearish, Adam Crystal

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.